The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033. Market growth is underpinned by a rapidly expanding AFib patient population, ...

Concerns about the lack of balanced information provided about left atrial appendage (LAA) closure procedures on the web pages of top US hospitals have been raised by a new study. The researchers ...

The ink is barely dry on the draft Medicare physician fee schedule for 2026, but three cardiology societies blasted the draft for cutting rates for left atrial appendage closure procedures – a move ...

A left atrial appendage (LAA) closure device provides long-term thromboembolic protection that is equivalent to direct oral anticoagulants after ablation for atrial fibrillation (AF), along with a ...

Erlanger Cardiology completed the first in Chattanooga concomitant left atrial appendage closure (LAAC) and cardiac ablation for atrial fibrillation (AFib) on Nov. 23. Officials said, "This is an ...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...

Patients with atrial fibrillation (AF) and a history of breakthrough stroke—an ischemic stroke that occurs despite use of oral anticoagulation—have a heightened risk for subsequent cerebrovascular ...

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...

Catheter Precision, Inc., a US medical device company specializing in cardiac electrophysiology, will attend the 13th International Symposium on Left Atrial Appendage (ISLAA) in Austin, Texas on ...